[Patent foramen ovale--demographic, clinical and echocardiographic characteristics]

Marek Maciejewski1, Marzenna Zielińska, Halina Bolinska

  • 1Klinika Kardiologii I Katedry Kardiologii i Kardiochirurgii Uniwersytetu Medycznego, Lodzi. marekmaciejewski@poczta.fm

Przeglad Lekarski
|March 29, 2005
PubMed

Insights

Patent foramen ovale (PFO) is a risk factor for systemic embolism/transient ischemic attack, but only when it is the sole cardiac abnormality. Minimal flow through PFO is typical in these cases.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Embryology

Background:

  • Patent foramen ovale (PFO) is the most common persistent fetal circulatory abnormality.
  • PFO is associated with an increased risk of paradoxical embolism.

Purpose of the Study:

  • To determine the incidence and characteristics of PFO.
  • To evaluate PFO as a risk factor for paradoxical embolism.

Main Methods:

  • Retrospective analysis of 945 patients undergoing TEE (transesophageal echocardiography) between 1998-2002.
  • Patients were categorized based on PFO presence and history of systemic embolism (SE) or transient ischemic attack (TIA).
  • Subgroup analysis compared patients with isolated PFO versus those with PFO and other cardiac/aortic diseases.

Main Results:

  • PFO was diagnosed in 57 patients (6%).
  • The incidence of SE/TIA was significantly higher in patients with isolated PFO (xPFO(+)) compared to controls without PFO (xPFO(-)).
  • Higher shunt intensity was observed in patients with PFO and coexisting heart disease (yPFO(+)) compared to isolated PFO (xPFO(+)).

Conclusions:

  • PFO is a risk factor for SE/TIA exclusively in patients with isolated PFO.
  • Flow through PFO in isolated cases is generally minimal.
  • Coexisting heart pathology can lead to significant right-to-left or left-to-right shunting through a PFO.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...